By Dr Jodie Abramovitch
Coeliac disease is a condition in which the immune system launches an inflammatory response to gluten. In healthy individuals, this immune reaction does not occur. Due to the inflammatory response, patients with coeliac disease typically have damaged small intestines which can lead to malnutrition, weight loss and gastrointestinal symptoms such as nausea and bloating.
Coeliac disease is a condition in which the immune system launches an inflammatory response to gluten. In healthy individuals, this immune reaction does not occur. Due to the inflammatory response, patients with coeliac disease typically have damaged small intestines which can lead to malnutrition, weight loss and gastrointestinal symptoms such as nausea and bloating.
A gluten-free diet is ‘prescribed’ for patients with coeliac
disease. Currently, prospective studies of the short and long term effects of a
gluten-free diet on the symptoms and pathology of coeliac disease are lacking.
Monash researchers from the Eastern Health Clinical School
and supervised by Professor Peter Gibson from the Department of Gastroenterology at the Central Clinical School aimed to determine the time
frame in which intestinal damage and associated nutritional deficiencies caused by coeliac disease were
successfully treated.
Ninety-nine subjects were recruited to the study at the time
of their diagnosis with coeliac disease and assessed over five years. Nearly all of the subjects adhered well to a gluten-free diet over the time course and,
consequently, the vast majority of subjects showed healing or near-healing of intestinal damage after five years. Furthermore,
patients had improved fat mass after one year on a gluten-free diet and lean (fat-free)
mass was improved after five years. In subjects with a loss of bone density (e.g. osteoporosis), which can occur in coeliac disease, bone density increased at both one and five years.
Reference: Newnham ED, Shepherd SJ, Strauss BJ, Hosking P, Gibson PR. Adherence to the gluten-free diet can achieve the therapeutic goals in almost all patients with coeliac disease: A 5-year longitudinal study from diagnosis. J Gastroenterol Hepatol. 2016 Feb: 31;342-9
doi: 10.1111/jgh.13060.
No comments:
Post a Comment
Thankyou for your comment. We moderate all messages and may take a little time to review your comment. Please email inquiries to ccs.comms@monash.edu.